Induction of Heme Oxygenase-1 Inhibits Monocyte Chemoattractant Protein-1 mRNA Expression in U937 Cells

Heme oxygenase-1 (HO-1) is a stress-inducible isoform of HO with potential cytoprotective effects. Monocyte activation/migration mediated by monocyte chemoattractant protein-1(MCP-1) is one of the earliest and important events in the pathogenesis of atherosclerosis. We examined the effect of HO-1 on...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of Pharmacological Sciences Ročník 100; číslo 2; s. 162 - 166
Hlavní autoři: Shokawa, Tomoki, Yoshizumi, Masao, Yamamoto, Hideya, Omura, Shinji, Toyofuku, Mamoru, Shimizu, Yoshito, Imazu, Michinori, Kohno, Nobuoki
Médium: Journal Article
Jazyk:angličtina
Vydáno: Japan The Japanese Pharmacological Society 2006
Elsevier
Témata:
ISSN:1347-8613
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Heme oxygenase-1 (HO-1) is a stress-inducible isoform of HO with potential cytoprotective effects. Monocyte activation/migration mediated by monocyte chemoattractant protein-1(MCP-1) is one of the earliest and important events in the pathogenesis of atherosclerosis. We examined the effect of HO-1 on the production of lysophosphatidylcholine (Lyso-PC)-induced MCP-1 in the human promonocytic cell line U937. Increased HO-1 induction by hemin resulted in a significant decrease in the Lyso-PC-mediated induction of MCP-1 mRNA expression. SnPP (IX), the specific inhibitor of HO-1 enzymatic activity, prevented the hemin-mediated attenuation of MCP-1 mRNA expression. These results suggest that HO-1 may work as an anti-atherogenic agent through the attenuation of MCP-1 production.
AbstractList Heme oxygenase-1 (HO-1) is a stress-inducible isoform of HO with potential cytoprotective effects. Monocyte activation/migration mediated by monocyte chemoattractant protein-1(MCP-1) is one of the earliest and important events in the pathogenesis of atherosclerosis. We examined the effect of HO-1 on the production of lysophosphatidylcholine (Lyso-PC)-induced MCP-1 in the human promonocytic cell line U937. Increased HO-1 induction by hemin resulted in a significant decrease in the Lyso-PC-mediated induction of MCP-1 mRNA expression. SnPP (IX), the specific inhibitor of HO-1 enzymatic activity, prevented the hemin-mediated attenuation of MCP-1 mRNA expression. These results suggest that HO-1 may work as an anti-atherogenic agent through the attenuation of MCP-1 production.
Heme oxygenase-1 (HO-1) is a stress-inducible isoform of HO with potential cytoprotective effects. Monocyte activation/migration mediated by monocyte chemoattractant protein-1 (MCP-1) is one of the earliest and important events in the pathogenesis of atherosclerosis. We examined the effect of HO-1 on the production of lysophosphatidylcholine (Lyso-PC)-induced MCP-1 in the human promonocytic cell line U937. Increased HO-1 induction by hemin resulted in a significant decrease in the Lyso-PC-mediated induction of MCP-1 mRNA expression. SnPP (IX), the specific inhibitor of HO-1 enzymatic activity, prevented the hemin-mediated attenuation of MCP-1 mRNA expression. These results suggest that HO-1 may work as an anti-atherogenic agent through the attenuation of MCP-1 production.Heme oxygenase-1 (HO-1) is a stress-inducible isoform of HO with potential cytoprotective effects. Monocyte activation/migration mediated by monocyte chemoattractant protein-1 (MCP-1) is one of the earliest and important events in the pathogenesis of atherosclerosis. We examined the effect of HO-1 on the production of lysophosphatidylcholine (Lyso-PC)-induced MCP-1 in the human promonocytic cell line U937. Increased HO-1 induction by hemin resulted in a significant decrease in the Lyso-PC-mediated induction of MCP-1 mRNA expression. SnPP (IX), the specific inhibitor of HO-1 enzymatic activity, prevented the hemin-mediated attenuation of MCP-1 mRNA expression. These results suggest that HO-1 may work as an anti-atherogenic agent through the attenuation of MCP-1 production.
Heme oxygenase-1 (HO-1) is a stress-inducible isoform of HO with potential cytoprotective effects. Monocyte activation/migration mediated by monocyte chemoattractant protein-1 (MCP-1) is one of the earliest and important events in the pathogenesis of atherosclerosis. We examined the effect of HO-1 on the production of lysophosphatidylcholine (Lyso-PC)-induced MCP-1 in the human promonocytic cell line U937. Increased HO-1 induction by hemin resulted in a significant decrease in the Lyso-PC-mediated induction of MCP-1 mRNA expression. SnPP (IX), the specific inhibitor of HO-1 enzymatic activity, prevented the hemin-mediated attenuation of MCP-1 mRNA expression. These results suggest that HO-1 may work as an anti-atherogenic agent through the attenuation of MCP-1 production. Keywords:: heme oxygenase-1, oxidized low-density lipoprotein, monocyte chemoattractant protein-1
Author Tomoki Shokawa
Hideya Yamamoto
Yoshito Shimizu
Michinori Imazu
Shinji Omura
Nobuoki Kohno
Masao Yoshizumi
Mamoru Toyofuku
Author_xml – sequence: 1
  givenname: Tomoki
  surname: Shokawa
  fullname: Shokawa, Tomoki
  organization: Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
– sequence: 2
  givenname: Masao
  surname: Yoshizumi
  fullname: Yoshizumi, Masao
– sequence: 3
  givenname: Hideya
  surname: Yamamoto
  fullname: Yamamoto, Hideya
– sequence: 4
  givenname: Shinji
  surname: Omura
  fullname: Omura, Shinji
– sequence: 5
  givenname: Mamoru
  surname: Toyofuku
  fullname: Toyofuku, Mamoru
– sequence: 6
  givenname: Yoshito
  surname: Shimizu
  fullname: Shimizu, Yoshito
– sequence: 7
  givenname: Michinori
  surname: Imazu
  fullname: Imazu, Michinori
– sequence: 8
  givenname: Nobuoki
  surname: Kohno
  fullname: Kohno, Nobuoki
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16474202$$D View this record in MEDLINE/PubMed
BookMark eNo9kU1vGyEQhjmkatI01x4rTr055WuBPUZWmljKR1U1ZwTsYGPtgruwUvzvS-u0F0Azj57RvHxAZyknQOgTJdeUdeLr_rAr18UTIgjV-gxdUC7USkvKz9FVKdERwjRjtOveo3MqhRKMsAu03aRh8TXmhHPA9zABfn49biHZAiuKN2kXXawFP-aU_bECXu9gyrbW2fpqU8Xf51whpsZOP55u8O3rYYY2rvliwi89V3gN41g-onfBjgWu3u5L9PLt9uf6fvXwfLdZ3zysvBK8rrjuguoHp5QgoAN3MATq7eB76MgQeAhglQ1tNVBWKjdwz7zjgXmvlAbLL9Hm5B2y3ZvDHCc7H0220fwt5Hlr7FyjH8EEcL0VupcKhAiUaO6EIswB7Ukz98315eQ6zPnXAqWaKRbftrEJ8lKMVFL2XLIGfn4DFzfB8H_sv5gbcHcCWjd6O-Y0xgRmn5c5tTSMD7L4CMkwQqQhlLTPMoTo9pTszyEpUS0bwX8DvniXMg
CitedBy_id crossref_primary_10_1371_journal_pcbi_1000943
crossref_primary_10_3109_1547691X_2011_558529
crossref_primary_10_1038_mi_2015_39
crossref_primary_10_1080_13880209_2018_1434549
crossref_primary_10_1155_2020_4585704
crossref_primary_10_1186_s12865_014_0052_1
crossref_primary_10_1111_jgh_12742
crossref_primary_10_1016_j_carbon_2007_06_054
crossref_primary_10_1291_hypres_30_341
crossref_primary_10_1371_journal_pone_0021358
crossref_primary_10_1189_jlb_0508280
crossref_primary_10_1124_jpet_109_152702
crossref_primary_10_1007_s00204_012_0845_z
crossref_primary_10_1016_j_injury_2007_08_041
crossref_primary_10_1089_jir_2008_0027
crossref_primary_10_1016_j_surg_2007_07_041
ContentType Journal Article
CorporateAuthor Hiroshima University
Department of Biomedical Chemistry
Department of Molecular and Internal Medicine
Graduate School of Biomedical Sciences
Department of Cardiovascular Physiology and Medicine
CorporateAuthor_xml – name: Department of Cardiovascular Physiology and Medicine
– name: Department of Biomedical Chemistry
– name: Department of Molecular and Internal Medicine
– name: Graduate School of Biomedical Sciences
– name: Hiroshima University
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1254/jphs.sc0040188
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EndPage 166
ExternalDocumentID oai_doaj_org_article_feb9a48967e44f1083b4702be1907bd9
16474202
cf6scien_2006_010002_008_0162_01661073854
Genre Journal Article
Comparative Study
GroupedDBID ---
.55
.GJ
0R~
29L
2WC
3O-
4.4
457
53G
5GY
5RE
AAEDT
AAEDW
AAIKJ
AALRI
AAXUO
AAYWO
ABMAC
ACGFO
ACGFS
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AENEX
AEUPX
AEXQZ
AFJKZ
AFPUW
AFTJW
AGHFR
AIGII
AITUG
AKBMS
AKRWK
AKYEP
AL-
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BAWUL
BCNDV
BKOMP
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FDB
GROUPED_DOAJ
GX1
HH5
IPNFZ
JMI
JSF
JSH
KQ8
M41
MOJWN
O9-
OK1
OVT
RIG
RJT
RNS
ROL
RZJ
SSZ
TKC
TR2
W2D
X7M
XSB
ZGI
ZXP
0SF
6I.
AACTN
AAFTH
CGR
CUY
CVF
ECM
EIF
M~E
NCXOZ
NPM
7X8
ID FETCH-LOGICAL-c743t-385f79db7740e8f3bedf1cadc9e50df3ffea7af347e7a67bd3c2cb3f2cc778ea3
IEDL.DBID DOA
ISICitedReferencesCount 23
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000235623100008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1347-8613
IngestDate Fri Oct 03 12:44:43 EDT 2025
Fri Jul 11 12:38:36 EDT 2025
Sat Sep 28 08:37:31 EDT 2024
Thu Jul 10 16:11:34 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c743t-385f79db7740e8f3bedf1cadc9e50df3ffea7af347e7a67bd3c2cb3f2cc778ea3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://doaj.org/article/feb9a48967e44f1083b4702be1907bd9
PMID 16474202
PQID 67669362
PQPubID 23479
PageCount 5
ParticipantIDs doaj_primary_oai_doaj_org_article_feb9a48967e44f1083b4702be1907bd9
proquest_miscellaneous_67669362
pubmed_primary_16474202
medicalonline_journals_cf6scien_2006_010002_008_0162_01661073854
PublicationCentury 2000
PublicationDate 2006-00-00
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – year: 2006
  text: 2006-00-00
PublicationDecade 2000
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Journal of Pharmacological Sciences
PublicationTitleAlternate J Pharmacol Sci
PublicationYear 2006
Publisher The Japanese Pharmacological Society
Elsevier
Publisher_xml – name: The Japanese Pharmacological Society
– name: Elsevier
SSID ssib002822155
ssib044745378
ssj0028016
ssib058493307
Score 1.8542116
Snippet Heme oxygenase-1 (HO-1) is a stress-inducible isoform of HO with potential cytoprotective effects. Monocyte activation/migration mediated by monocyte...
SourceID doaj
proquest
pubmed
medicalonline
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 162
SubjectTerms Chemokine CCL2 - antagonists & inhibitors
Chemokine CCL2 - genetics
Dose-Response Relationship, Drug
Enzyme Induction
Gene Expression Regulation - drug effects
Heme Oxygenase-1 - biosynthesis
Heme Oxygenase-1 - genetics
Humans
Lysophosphatidylcholines - pharmacology
Monocytes - cytology
Monocytes - drug effects
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - metabolism
RNA, Ribosomal, 18S - metabolism
Time Factors
U937 Cells
Title Induction of Heme Oxygenase-1 Inhibits Monocyte Chemoattractant Protein-1 mRNA Expression in U937 Cells
URI http://mol.medicalonline.jp/en/journal/download?GoodsID=cf6scien/2006/010002/008&name=0162-0166e
https://www.ncbi.nlm.nih.gov/pubmed/16474202
https://www.proquest.com/docview/67669362
https://doaj.org/article/feb9a48967e44f1083b4702be1907bd9
Volume 100
WOSCitedRecordID wos000235623100008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  issn: 1347-8613
  databaseCode: M~E
  dateStart: 20030101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://road.issn.org
  omitProxy: false
  ssIdentifier: ssib044745378
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELag4gBCiDfLo_iAemponHjt-EZZbVUkukTQSnuzbGdMg7pJ1aSoe-G3M3ZSFg6IC5c5RDk4M_bMNxnPN4S84aKq0OtliapYKDNKldhp7hNImRMeEAFAZNf_KBeLYrlU5W-jvsKdsIEeeFDcngerDC-UkMC5Z4gYLJdpZgEjmbRVbN1D1HOdTI2pFvrd2FeUc_TBGLFGukbMhva-nZ92b7_Mwu5lYd5KpOq_Q-6uhsLIQFDxd7wZ487BfXJvBIx0f1joA3IDmodkpxwYp9e79HjTQNXt0h1abrio14_I1zCaI7Yu0NbTQ1gB_XS1xk2DwSth9ENzWtu67yge7date6CBQKA1fR-ap1DptAw8DnWD764-L_bp_Gq8ONvQuqEniDroDM7Ousfk5GB-PDtMxtkKiUPM0Cd5MfVSVRbRXwqFzy1UnjlTOQXTtPK592Ck8ag_kEagonOXOZv7zDkpCzD5E7LVtA08I1RC4VzhERioinMwBjM45pk1zHjHrZ-Q90HF-nygz9CB0Do-QDPr0cz6X2aekHd_GEiPR63TzosIFsJATaHTUK_IdJytyUQWBALEQNnDJ-T1tU01nqFQGDENtJedFlIIhZF8Qp4Opv611sC2xrM0e_4_vuEFub35gfOSbPUXl_CK3HLf-7q72CY35bLYjtsY5dGPOcpFefQTFpn3kQ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Induction+of+Heme+Oxygenase-1+Inhibits+Monocyte+Chemoattractant+Protein-1+mRNA+Expression+in+U937+Cells&rft.jtitle=Journal+of+Pharmacological+Sciences&rft.au=Tomoki+Shokawa&rft.au=Masao+Yoshizumi&rft.au=Hideya+Yamamoto&rft.au=Shinji+Omura&rft.date=2006&rft.pub=The+Japanese+Pharmacological+Society&rft.issn=1347-8613&rft.volume=100&rft.issue=2&rft.spage=162&rft.epage=166&rft_id=info:doi/10.1254%2Fjphs.sc0040188&rft.externalDocID=cf6scien_2006_010002_008_0162_01661073854
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-8613&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-8613&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-8613&client=summon